ESCAPE-NEXT is a multicentre, randomized, double-blinded, placebo-controlled, parallel Group, singledose trial designed to determine the efficacy and safety of nerinetide in participants with acute ischemic stroke undergoing endovascular thrombectomy excluding thrombolysis.

ESCAPE-NEXT is a custom designed Electronic Data Capture (EDC), Randomization and Drug Management (RDM) Interactive Resposive Technology (IRT) developed for the purpose of facilitating the data collection for the ESCAPE-NEXT Trial, while providing the following functions:

  • Enables randomization of subjects based on a minimal sufficient balance algorithm
  • Provides the ability to record and store patient profiles
  • Provides drug management capabilities across multiple sites/locations
  • Provides functionality for validating the randomization of subjects
  • Provides an API integration with the IBM EDC solution
  • Provides a finance module for generating invoices based on patient enrollment and follow-up visits during the trial
  • Dashboards, charts and reports
  • Secure & Scalable

Other Links:

Ready to build?Get started today.

At heart, we are a dynamic and open-minded group of individuals that want to help companies succeed. First and foremost, we are critical thinkers and problem solvers.

Contact Us
App screenshot